Ceramide Induces Interleukin 6 Gene Expression in Human Fibroblasts

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1995 Aug 1

PMID 7629516

Citations 16

Authors

S J Laulederkind

A Bielawska

R Raghow

Y A Hannun

L R Ballou

Affiliations

Soon will be listed here.

Abstract

We previously reported that ceramide, the immediate product of sphingomyelin hydrolysis, increases in response to interleukin (IL)-1 beta and plays a role in modulating IL-1 beta-mediated prostaglandin E2 production and cyclooxygenase gene expression in human fibroblasts (Ballou, L. R., C. P. Chao, M. A. Holness, S. C. Barker, and R. Raghow. 1992. J. Biol. Chem. 267:20044-20050). Here we describe the effects of ceramide in another IL-1 beta-mediated process in these cells, the induction of IL-6 production. We found that submicromolar concentrations of C2-ceramide induced IL-6 gene expression and protein production as effectively as IL-1 beta. Both D-erythro-C2-ceramide (a cell-permeable analogue of natural ceramide) and D-threo-C2-ceramide were potent inducers of IL-6 production, while neither L isomer of ceramide was effective. Compared with IL-1 beta-induced IL-6 production, cells treated with ceramide or exogenous sphingomyelinase induced 82 and 50% of maximal IL-1 beta-induced IL-6 levels by 6 h, respectively; by 24 h all three treatments induced similar levels of IL-6 production. Ceramide-induced IL-6 messenger RNA could be detected within 1 h of treatment and reached maximal levels by 24 h. These findings suggest that ceramide may play a role in the regulation of IL-6 gene expression.

Citing Articles

The therapeutic potential of sphingolipids for cardiovascular diseases.

Yaar Bar S, Pintel N, Abd Alghne H, Khattib H, Avni D Front Cardiovasc Med. 2023; 10:1224743.

PMID: 37608809 PMC: 10440740. DOI: 10.3389/fcvm.2023.1224743.

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.

Di Pietro P, Izzo C, Abate A, Iesu P, Rusciano M, Venturini E Biomolecules. 2023; 13(1).

PMID: 36671552 PMC: 9855992. DOI: 10.3390/biom13010168.

Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer.

Lin H, Yeung N, Hastings J, Croucher D, Huynh K, Meikle T Cancers (Basel). 2021; 13(19).

PMID: 34638448 PMC: 8508038. DOI: 10.3390/cancers13194964.

Acid Sphingomyelinase and Acid β-Glucosidase 1 Exert Opposite Effects on Interleukin-1β-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Zhao M, Yang M, Li X, Hou L, Liu X, Xiao W Inflammation. 2021; 44(4):1592-1606.

PMID: 33665756 DOI: 10.1007/s10753-021-01444-9.

Acid sphingomyelinase downregulation alleviates vascular endothelial leptin resistance in rats.

Cai B, Lu Y, Xu M Acta Pharmacol Sin. 2019; 41(5):650-660.

PMID: 31848475 PMC: 7471453. DOI: 10.1038/s41401-019-0328-3.

References

Okazaki T, Bell R, Hannun Y . Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem. 1989; 264(32):19076-80. View

Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M . Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 1994; 78(6):1005-15. DOI: 10.1016/0092-8674(94)90275-5. View

Zhang Y, Lin J, Vilcek J . Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol. 1990; 10(7):3818-23. PMC: 360846. DOI: 10.1128/mcb.10.7.3818-3823.1990. View

Akira S, Hirano T, Taga T, Kishimoto T . Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990; 4(11):2860-7. View

Ray A, LaForge K, Sehgal P . On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol. 1990; 10(11):5736-46. PMC: 361346. DOI: 10.1128/mcb.10.11.5736-5746.1990. View

Kim M, Linardic C, Obeid L, Hannun Y . Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem. 1991; 266(1):484-9. View

Hirano T, Akira S, Taga T, Kishimoto T . Biological and clinical aspects of interleukin 6. Immunol Today. 1990; 11(12):443-9. DOI: 10.1016/0167-5699(90)90173-7. View

Dressler K, Mathias S, Kolesnick R . Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science. 1992; 255(5052):1715-8. DOI: 10.1126/science.1313189. View

Hirano T . The biology of interleukin-6. Chem Immunol. 1992; 51:153-80. View

10.

Lee F . The role of interleukin-6 in development. Dev Biol. 1992; 151(2):331-8. DOI: 10.1016/0012-1606(92)90173-e. View

11.

Linardic C, Jayadev S, Hannun Y . Brefeldin A promotes hydrolysis of sphingomyelin. J Biol Chem. 1992; 267(21):14909-11. View

12.

Bielawska A, Linardic C, Hannun Y . Modulation of cell growth and differentiation by ceramide. FEBS Lett. 1992; 307(2):211-4. DOI: 10.1016/0014-5793(92)80769-d. View

13.

Kishimoto T . Interleukin-6 and its receptor in autoimmunity. J Autoimmun. 1992; 5 Suppl A:123-32. DOI: 10.1016/0896-8411(92)90027-n. View

14.

Akira S, Kishimoto T . IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev. 1992; 127:25-50. DOI: 10.1111/j.1600-065x.1992.tb01407.x. View

15.

Ballou L, Chao C, Holness M, Barker S, Raghow R . Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem. 1992; 267(28):20044-50. View

16.

Kishimoto T, Akira S, Taga T . Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992; 258(5082):593-7. DOI: 10.1126/science.1411569. View

17.

Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M . TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 1992; 71(5):765-76. DOI: 10.1016/0092-8674(92)90553-o. View

18.

Sehgal P . Regulation of IL6 gene expression. Res Immunol. 1992; 143(7):724-34. DOI: 10.1016/0923-2494(92)80011-9. View

19.

Ballou L . Sphingolipids and cell function. Immunol Today. 1992; 13(9):339-41. DOI: 10.1016/0167-5699(92)90167-6. View

20.

Mathias S, Younes A, Kan C, Orlow I, Joseph C, Kolesnick R . Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science. 1993; 259(5094):519-22. DOI: 10.1126/science.8424175. View